高级检索
当前位置: 首页 > 详情页

The Null Polymorphism of the GSTM1/T1 Gene Is Not Associated with Susceptibility to Systemic Lupus Erythematosus: A Meta-Analysis

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

机构: [1]Department of Dermatology, First Affiliated Hospital of Kunming Medical University, 295 Xichang Road, Kunming, Yunnan 650032, China [2]Department of Physiology, School of Basic Medical Sciences, Kunming Medical University, Kunming, Yunnan, China [3]Division of Science and Research, Kunming Medical University, Kunming, Yunnan, China [4]Center of Functional Experiment, Kunming Medical University, Kunming, Yunnan, China
出处:
ISSN:

摘要:
Previous studies have suggested that the null polymorphism of the glutathione S-transferases M1/T1 (GSTM1/T1) gene may be associated with the risk of developing systemic lupus erythematosus (SLE). We further explored this potential association using a meta-analysis. A systematic literature search was carried out in the scientific literature databases and we used odds ratios (OR) and 95 % confidence intervals (CIs) to evaluate the strength of this association. All statistical analyses were calculated using Stata software 11.0, and Bonferroni correction was used to adjust the p values. Nine eligible articles with 1,850 patients and 2,826 controls were identified. Our results showed the null polymorphism of the GSTM1 gene was associated with SLE in East Asians (OR 1.32, 95 % CI 1.04-1.69, p = 0.024), but not in Europeans and Africans. However, when Bonferroni corrections were applied (p = 0.05/2 = 0.025), we could not be sure of this association. We further analysed the associations between the GSTT1 gene null polymorphism and the risk of SLE. The results of this investigation showed that this null polymorphism was not associated with susceptibility to SLE in all included populations. In conclusion, the null polymorphism of GSTM1/T1 gene may not be associated with the risk of SLE. More studies are needed to confirm this lack of association between key oxidative defense genes and susceptibility to SLE in the future.

基金:

基金编号: 2013FB044 2014FB008 2014Y165

语种:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2016]版:
大类 | 3 区 医学
小类 | 3 区 遗传学 3 区 药学
最新[2023]版:
大类 | 3 区 医学
小类 | 3 区 遗传学 3 区 药学
JCR分区:
出版当年[2015]版:
Q2 GENETICS & HEREDITY Q2 PHARMACOLOGY & PHARMACY
最新[2023]版:
Q1 GENETICS & HEREDITY Q1 PHARMACOLOGY & PHARMACY

影响因子: 最新[2023版] 最新五年平均 出版当年[2015版] 出版当年五年平均 出版前一年[2014版] 出版后一年[2016版]

第一作者:
第一作者机构: [1]Department of Dermatology, First Affiliated Hospital of Kunming Medical University, 295 Xichang Road, Kunming, Yunnan 650032, China [2]Department of Physiology, School of Basic Medical Sciences, Kunming Medical University, Kunming, Yunnan, China
共同第一作者:
通讯作者:
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:52537 今日访问量:0 总访问量:1562 更新日期:2024-09-01 建议使用谷歌、火狐浏览器 常见问题

版权所有©2020 昆明医科大学第一附属医院 技术支持:重庆聚合科技有限公司 地址:云南省昆明市西昌路295号(650032)